Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Cyst | 7 | 2016 | 348 | 0.630 |
Why?
|
| Adenocarcinoma, Mucinous | 5 | 2016 | 483 | 0.620 |
Why?
|
| Endosonography | 9 | 2014 | 576 | 0.560 |
Why?
|
| Pancreatic Neoplasms | 12 | 2021 | 5022 | 0.490 |
Why?
|
| Biopsy, Needle | 4 | 2006 | 1679 | 0.240 |
Why?
|
| Papilloma, Intraductal | 1 | 2002 | 21 | 0.240 |
Why?
|
| Biliary Tract Neoplasms | 2 | 2016 | 176 | 0.220 |
Why?
|
| Cholestasis | 2 | 2016 | 361 | 0.210 |
Why?
|
| Cystadenoma, Serous | 1 | 2021 | 101 | 0.210 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2001 | 54 | 0.200 |
Why?
|
| Carcinoma, Papillary | 2 | 2016 | 797 | 0.200 |
Why?
|
| Duodenal Diseases | 1 | 2001 | 102 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2016 | 1521 | 0.190 |
Why?
|
| Pancreaticoduodenectomy | 2 | 2021 | 518 | 0.190 |
Why?
|
| Cholangitis | 1 | 2020 | 107 | 0.190 |
Why?
|
| Pancreatic Ducts | 2 | 2011 | 335 | 0.170 |
Why?
|
| Carcinoembryonic Antigen | 2 | 2016 | 350 | 0.170 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2007 | 1062 | 0.170 |
Why?
|
| Lower Gastrointestinal Tract | 1 | 2007 | 15 | 0.160 |
Why?
|
| Endoscopy, Digestive System | 3 | 2016 | 335 | 0.160 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2010 | 490 | 0.160 |
Why?
|
| Intestinal Obstruction | 1 | 2001 | 424 | 0.160 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2007 | 34 | 0.160 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 272 | 0.150 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2014 | 1063 | 0.150 |
Why?
|
| Chromogranins | 1 | 2016 | 174 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2022 | 809 | 0.140 |
Why?
|
| Hiccup | 1 | 2005 | 8 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 2 | 2011 | 1486 | 0.140 |
Why?
|
| Duodenoscopes | 1 | 2005 | 43 | 0.140 |
Why?
|
| Choledocholithiasis | 1 | 2005 | 51 | 0.130 |
Why?
|
| Lithotripsy | 1 | 2005 | 139 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2016 | 217 | 0.130 |
Why?
|
| Stents | 2 | 2010 | 3309 | 0.130 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2014 | 113 | 0.120 |
Why?
|
| Ampulla of Vater | 1 | 2014 | 142 | 0.120 |
Why?
|
| Palliative Care | 3 | 2010 | 3291 | 0.120 |
Why?
|
| Mucins | 1 | 2006 | 557 | 0.120 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2005 | 237 | 0.120 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2014 | 214 | 0.110 |
Why?
|
| Cystadenocarcinoma, Mucinous | 1 | 2011 | 49 | 0.110 |
Why?
|
| Vomiting | 1 | 2005 | 628 | 0.110 |
Why?
|
| Esophageal Neoplasms | 2 | 2006 | 1535 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2007 | 753 | 0.100 |
Why?
|
| Barrett Esophagus | 1 | 2005 | 486 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 2142 | 0.100 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 1224 | 0.100 |
Why?
|
| Esophagus | 2 | 2006 | 1018 | 0.100 |
Why?
|
| Cytodiagnosis | 1 | 2014 | 420 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 6370 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 1308 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1671 | 0.090 |
Why?
|
| Ethanol | 1 | 2005 | 1260 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 538 | 0.090 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 1871 | 0.070 |
Why?
|
| Transducers | 1 | 2006 | 247 | 0.070 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 13276 | 0.060 |
Why?
|
| Liver | 1 | 2009 | 7628 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2563 | 0.060 |
Why?
|
| Adenoma | 1 | 2014 | 2118 | 0.060 |
Why?
|
| Middle Aged | 17 | 2022 | 215054 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 3 | 2011 | 3704 | 0.060 |
Why?
|
| Stomach Neoplasms | 2 | 2006 | 1262 | 0.060 |
Why?
|
| Fatal Outcome | 2 | 2009 | 1892 | 0.060 |
Why?
|
| Male | 19 | 2022 | 351399 | 0.050 |
Why?
|
| Retrospective Studies | 10 | 2020 | 72608 | 0.050 |
Why?
|
| Aged | 13 | 2020 | 162862 | 0.050 |
Why?
|
| Candidiasis, Oral | 1 | 2009 | 55 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 58528 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2009 | 132 | 0.040 |
Why?
|
| Equipment Design | 3 | 2010 | 3631 | 0.040 |
Why?
|
| Pancreas | 2 | 2021 | 1693 | 0.040 |
Why?
|
| Humans | 24 | 2022 | 717280 | 0.040 |
Why?
|
| Hemorrhoids | 1 | 2007 | 21 | 0.040 |
Why?
|
| Pancreatitis | 1 | 2004 | 1064 | 0.040 |
Why?
|
| Angiodysplasia | 1 | 2007 | 18 | 0.040 |
Why?
|
| Female | 16 | 2021 | 377934 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 39302 | 0.040 |
Why?
|
| Diverticulum | 1 | 2007 | 133 | 0.040 |
Why?
|
| Pancreatectomy | 1 | 2021 | 855 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2009 | 656 | 0.040 |
Why?
|
| Duodenal Obstruction | 1 | 2005 | 23 | 0.030 |
Why?
|
| Probability | 1 | 2001 | 2489 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 14904 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 8944 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2014 | 15126 | 0.030 |
Why?
|
| Prognosis | 3 | 2014 | 29226 | 0.030 |
Why?
|
| Octreotide | 1 | 2005 | 150 | 0.030 |
Why?
|
| Amylases | 1 | 2014 | 188 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 578 | 0.030 |
Why?
|
| Suction | 1 | 2005 | 262 | 0.030 |
Why?
|
| Cyst Fluid | 1 | 2014 | 69 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2005 | 306 | 0.030 |
Why?
|
| Duodenal Neoplasms | 1 | 2014 | 111 | 0.030 |
Why?
|
| Antiemetics | 1 | 2005 | 172 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2005 | 290 | 0.030 |
Why?
|
| Haloperidol | 1 | 2005 | 396 | 0.030 |
Why?
|
| Health Resources | 1 | 2019 | 924 | 0.030 |
Why?
|
| Adult | 8 | 2019 | 212470 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2016 | 62344 | 0.030 |
Why?
|
| Nausea | 1 | 2005 | 658 | 0.030 |
Why?
|
| Recurrence | 2 | 2016 | 8284 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 29491 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2006 | 11200 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1779 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2014 | 20435 | 0.030 |
Why?
|
| Emergencies | 1 | 2007 | 1126 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6282 | 0.020 |
Why?
|
| Safety | 1 | 2005 | 1220 | 0.020 |
Why?
|
| Colitis | 1 | 2007 | 1133 | 0.020 |
Why?
|
| Colectomy | 1 | 2014 | 650 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2011 | 39891 | 0.020 |
Why?
|
| Weight Loss | 1 | 2009 | 2495 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2001 | 10542 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2005 | 1952 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4312 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2006 | 51277 | 0.020 |
Why?
|
| Metals | 1 | 2010 | 694 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2005 | 1544 | 0.020 |
Why?
|
| Young Adult | 3 | 2019 | 56249 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 820 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2005 | 4921 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1801 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2008 | 5948 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2014 | 2365 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 19537 | 0.020 |
Why?
|
| Prevalence | 1 | 2019 | 14899 | 0.010 |
Why?
|
| Stomach | 1 | 2006 | 674 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 8068 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 13262 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 3016 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2011 | 2334 | 0.010 |
Why?
|
| Lung | 1 | 2009 | 9781 | 0.010 |
Why?
|
| Hospitalization | 1 | 2019 | 9754 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 15271 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 7056 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 85143 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2006 | 2975 | 0.010 |
Why?
|
| Risk Factors | 2 | 2020 | 70863 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 11008 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 34503 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2006 | 3433 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 7177 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 13716 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 9975 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 23543 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 23409 | 0.000 |
Why?
|
| United States | 1 | 2004 | 67804 | 0.000 |
Why?
|
Concepts
(148)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_